Kalanchoe pinnata (Lam.) Pers. Leaf ethanolic extract exerts selective anticancer activity through ROS-induced apoptotic cell death in human cancer cell lines.

IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE BMC Complementary Medicine and Therapies Pub Date : 2024-07-15 DOI:10.1186/s12906-024-04570-7
Nicolas Faundes-Gandolfo, Carlos Jara-Gutiérrez, Mario Párraga, Iván Montenegro, Waleska Vera, Marcela Escobar, Alejandro Madrid, Manuel Valenzuela-Valderrama, Joan Villena
{"title":"Kalanchoe pinnata (Lam.) Pers. Leaf ethanolic extract exerts selective anticancer activity through ROS-induced apoptotic cell death in human cancer cell lines.","authors":"Nicolas Faundes-Gandolfo, Carlos Jara-Gutiérrez, Mario Párraga, Iván Montenegro, Waleska Vera, Marcela Escobar, Alejandro Madrid, Manuel Valenzuela-Valderrama, Joan Villena","doi":"10.1186/s12906-024-04570-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against cancer in several countries worldwide; however, its therapeutic potential to fight cancer has been little addressed. In this study, we analyzed the phytochemical content, antioxidant capacity, and selectivity of K. pinnata leaf ethanolic extract against different human cancer cell lines in vitro.</p><p><strong>Methodology: </strong>This study subjected the ethanolic extract to enzymatic assays to quantify the phytochemical content (phenolics, flavonoids, and anthraquinones) and its radical scavenging and iron-reducing capacities. Also, the phytoconstituents and major phenolic compounds present in the extract's subfractions were identified by GC-MS, HPLC, and NMR. Human cancer (MCF-7, PC-3, HT-29) and normal colon (CoN) cell lines were treated with different concentrations of K. pinnata leaf ethanolic extract, and the changes in cell proliferation (sulforhodamine B assay), caspases activity (FITC-VAD-FMK reporter), mitochondrial membrane potential (MMP, rhodamine 123 assay), chromatin condensation/fragmentation (Hoechst 33342 stain), and ROS generation (DCFH<sub>2</sub> probe assay) were assessed.</p><p><strong>Results: </strong>The results showed that the K. pinnata leaf ethanolic extract is rich in phytoconstituents with therapeutic potential, including phenols (quercetin and kaempferol), flavonoids, fatty acid esters (34.6% of the total composition), 1- triacontanol and sterols (ergosterol and stigmasterol, 15.4% of the total composition); however, it presents a poor content of antioxidant molecules (IC<sub>50</sub> = 27.6 mg/mL for H<sub>2</sub>O<sub>2</sub> scavenging activity vs. 2.86 mg/mL in the case of Trolox). Notably, the extract inhibited cell proliferation and reduced MMP in all human cell lines tested but showed selectivity for HT-29 colon cancer cells compared to CoN normal cells (SI = 8.4). Furthermore, ROS generation, caspase activity, and chromatin condensation/fragmentation were augmented significantly in cancer-derived cell lines, indicating a selective cytotoxic effect.</p><p><strong>Conclusion: </strong>These findings reveal that the K. pinnata leaf ethanolic extract contains several bioactive molecules with therapeutic potential, capable of displaying selective cytotoxicity in different human cancer cell lines.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11247786/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Complementary Medicine and Therapies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12906-024-04570-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against cancer in several countries worldwide; however, its therapeutic potential to fight cancer has been little addressed. In this study, we analyzed the phytochemical content, antioxidant capacity, and selectivity of K. pinnata leaf ethanolic extract against different human cancer cell lines in vitro.

Methodology: This study subjected the ethanolic extract to enzymatic assays to quantify the phytochemical content (phenolics, flavonoids, and anthraquinones) and its radical scavenging and iron-reducing capacities. Also, the phytoconstituents and major phenolic compounds present in the extract's subfractions were identified by GC-MS, HPLC, and NMR. Human cancer (MCF-7, PC-3, HT-29) and normal colon (CoN) cell lines were treated with different concentrations of K. pinnata leaf ethanolic extract, and the changes in cell proliferation (sulforhodamine B assay), caspases activity (FITC-VAD-FMK reporter), mitochondrial membrane potential (MMP, rhodamine 123 assay), chromatin condensation/fragmentation (Hoechst 33342 stain), and ROS generation (DCFH2 probe assay) were assessed.

Results: The results showed that the K. pinnata leaf ethanolic extract is rich in phytoconstituents with therapeutic potential, including phenols (quercetin and kaempferol), flavonoids, fatty acid esters (34.6% of the total composition), 1- triacontanol and sterols (ergosterol and stigmasterol, 15.4% of the total composition); however, it presents a poor content of antioxidant molecules (IC50 = 27.6 mg/mL for H2O2 scavenging activity vs. 2.86 mg/mL in the case of Trolox). Notably, the extract inhibited cell proliferation and reduced MMP in all human cell lines tested but showed selectivity for HT-29 colon cancer cells compared to CoN normal cells (SI = 8.4). Furthermore, ROS generation, caspase activity, and chromatin condensation/fragmentation were augmented significantly in cancer-derived cell lines, indicating a selective cytotoxic effect.

Conclusion: These findings reveal that the K. pinnata leaf ethanolic extract contains several bioactive molecules with therapeutic potential, capable of displaying selective cytotoxicity in different human cancer cell lines.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Kalanchoe pinnata (Lam.) Pers.叶乙醇提取物通过 ROS 诱导的细胞凋亡在人类癌细胞系中发挥选择性抗癌活性。
背景:Kalanchoe pinnata (Lam.) Pers.(K.pinnata)是一种原产于热带地区的肉质植物,在世界多个国家被用作抗癌药物的替代品;然而,其抗癌治疗潜力却鲜有人问津。在这项研究中,我们分析了羽扇豆叶乙醇提取物的植物化学成分含量、抗氧化能力以及对不同人类癌细胞株的体外选择性:本研究对乙醇提取物进行酶学检测,以量化其植物化学成分(酚类、黄酮类和蒽醌类)含量及其自由基清除能力和铁还原能力。此外,还通过气相色谱-质谱(GC-MS)、高效液相色谱(HPLC)和核磁共振(NMR)鉴定了提取物亚组分中的植物成分和主要酚类化合物。人类癌症细胞株(MCF-7、PC-3、HT-29)和正常结肠细胞株(CoN)用不同浓度的 K.羽扇豆叶乙醇提取物处理人癌症细胞株(MCF-7、PC-3、HT-29)和正常结肠细胞株(CoN),并评估细胞增殖(苏尔福达明 B 检测法)、Caspases 活性(FITC-VAD-FMK 报告)、线粒体膜电位(MMP,罗丹明 123 检测法)、染色质凝集/破碎(Hoechst 33342 染色法)和 ROS 生成(DCFH2 探针检测法)的变化:结果表明,羽扇豆叶乙醇提取物富含具有治疗潜力的植物成分,包括酚类(槲皮素和山柰酚)、黄酮类、脂肪酸酯(占总成分的 34.6%)、1-三碳醇和甾醇(麦角甾醇和豆固醇,占总成分的 15.4%);但是,它的抗氧化分子含量较低(H2O2 清除活性的 IC50 = 27.6 mg/mL,而 Trolox 的 IC50 为 2.86 mg/mL)。值得注意的是,该提取物可抑制细胞增殖并降低所有受测人类细胞系的 MMP,但与 CoN 正常细胞相比,它对 HT-29 结肠癌细胞具有选择性(SI = 8.4)。此外,ROS 生成、Caspase 活性和染色质凝结/碎裂在癌症衍生细胞系中显著增强,表明其具有选择性细胞毒性作用:这些研究结果表明,羽扇豆叶乙醇提取物含有多种具有治疗潜力的生物活性分子,能够对不同的人类癌细胞系产生选择性细胞毒性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Complementary Medicine and Therapies
BMC Complementary Medicine and Therapies INTEGRATIVE & COMPLEMENTARY MEDICINE-
CiteScore
6.10
自引率
2.60%
发文量
300
审稿时长
19 weeks
期刊最新文献
Use of complementary and alternative medicine in patients with chronic liver diseases in Germany- a multicentric observational study. Gegen Qinlian decoction alleviates depression-like behavior by modulating the gut microenvironment in CUMS rats. Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. Synergistic effect of curcumin and tamoxifen loaded in pH-responsive gemini surfactant nanoparticles on breast cancer cells. The effectiveness of phytosomal curcumin on clinical and laboratory parameters of patients with multiple trauma admitted to the intensive care unit: a double-blind randomized placebo-controlled trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1